Glutamate dehydrogenase (GDH) catalyses the reversible oxidative deamination of glutamate to α-ketoglutarate. This mitochondrial enzyme is regulated by negative cooperativity and a wide array of allosteric effectors. Among them, most potent inhibitor GTP and most potent activator ADP. The importance of GDH regulation has been highlighted by the discovery of the hyperinsulinism-hyperammonaemia (HI/HA) syndrome. It is caused by dominant activating mutations that abrogate GTP inhibition, resulting in dangerously high serum levels of insulin and ammonium
OBJECTIVE: The combination of persistent hyperammonemia and hypoketotic hypoglycemia in i...
textabstractOBJECTIVE: The combination of persistent hyperammonemia and hypoketotic hypog...
The hyperinsulinism/hyperammonemia (HI/HA) syndrome is a rare autosomal dominant disease manifested ...
Glutamate dehydrogenase (GDH) catalyses the reversible oxidative deamination of glutamate to α-ketog...
Gain-of-function mutations in the GLUD1 gene, encoding for glutamate dehydrogenase (GDH), result in ...
Congenital hyperinsulinism/hyperammonemia (HI/HA) syndrome gives rise to unregulated protein-induced...
Congenital hyperinsulinism/hyperammonemia (HI/HA) syndrome gives rise to unregulated protein-induced...
Congenital hyperinsulinism/hyperammonemia (HI/HA) syndrome gives rise to unregulated protein-induced...
Glutamate dehydrogenase (GDH) is a hexameric enzyme that catalyzes the reversible conversion of glut...
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoalle...
Glutamate dehydrogenase (GDH) is a hexameric enzyme that catalyzes the reversible conversion of glut...
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoalle...
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoalle...
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoalle...
Impaired liver function may lead to hyperammonemia and risk for hepatic encephalopathy. In brain, de...
OBJECTIVE: The combination of persistent hyperammonemia and hypoketotic hypoglycemia in i...
textabstractOBJECTIVE: The combination of persistent hyperammonemia and hypoketotic hypog...
The hyperinsulinism/hyperammonemia (HI/HA) syndrome is a rare autosomal dominant disease manifested ...
Glutamate dehydrogenase (GDH) catalyses the reversible oxidative deamination of glutamate to α-ketog...
Gain-of-function mutations in the GLUD1 gene, encoding for glutamate dehydrogenase (GDH), result in ...
Congenital hyperinsulinism/hyperammonemia (HI/HA) syndrome gives rise to unregulated protein-induced...
Congenital hyperinsulinism/hyperammonemia (HI/HA) syndrome gives rise to unregulated protein-induced...
Congenital hyperinsulinism/hyperammonemia (HI/HA) syndrome gives rise to unregulated protein-induced...
Glutamate dehydrogenase (GDH) is a hexameric enzyme that catalyzes the reversible conversion of glut...
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoalle...
Glutamate dehydrogenase (GDH) is a hexameric enzyme that catalyzes the reversible conversion of glut...
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoalle...
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoalle...
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoalle...
Impaired liver function may lead to hyperammonemia and risk for hepatic encephalopathy. In brain, de...
OBJECTIVE: The combination of persistent hyperammonemia and hypoketotic hypoglycemia in i...
textabstractOBJECTIVE: The combination of persistent hyperammonemia and hypoketotic hypog...
The hyperinsulinism/hyperammonemia (HI/HA) syndrome is a rare autosomal dominant disease manifested ...